Evaluation of Benztropine for Cocaine Craving - 2
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders
Intervention: Benztropine (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
Steven Deutsch, M.D., Principal Investigator, Affiliation: Washington DC VA
Summary
The purpose of this study is to compare the efficacy of benztropine (or DA reuptake
inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues.
Clinical Details
Official title: Evaluation of Efficacy of Benztropine for Cocaine Craving
Study design: Treatment
Primary outcome: Stimulated and non-stimulated craving
Eligibility
Minimum age: 22 Years.
Maximum age: 48 Years.
Gender(s): Both.
Criteria:
Please contact site for information.
Locations and Contacts
Washington DC VA, Washington, District of Columbia 20422, United States
Additional Information
Last updated: June 23, 2005
|
